Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and susceptibility to ischemic stroke: A meta-analysis

Gene

Volumn 535, Issue 2, 2014, Pages 359-364

  Li, Pingping ^a   Qin, Chao ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; MTHFR gene polymorphism; Stroke

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2) GENE; ARTICLE; BRAIN ISCHEMIA; DNA POLYMORPHISM; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL;

CI; COMPUTED TOMOGRAPHY; CONFIDENCE INTERVAL; CT; MAGNETIC RESONANCE IMAGING; META-ANALYSIS; METHYLENETETRAHYDROFOLATE REDUCTASE; MRI; MTHFR; MTHFR GENE POLYMORPHISM; ODDS RATIO; OR; STROKE;

ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, GENETIC; STROKE;

EID: 84891049130     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.066     Document Type: Article

References (43)

1. Al-Allawi N.A., Avo A.S., Jubrael J.M. Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke. Neurol. India 2009, 57(5):631-635.
2. Ariyaratnam R., et al. Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med. 2007, 4(4):e131.
3. Banerjee I., Gupta V., Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J. Hum. Genet. 2007, 52(3):205-219.
4. Brass L.M., et al. A study of twins and stroke. Stroke 1992, 23(2):221-223.
5. Casas J.P., et al. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch. Neurol. 2004, 61(11):1652-1661.
6. Choi B.O., et al. Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb. Res. 2003, 111(1-2):39-44.
7. Cronin S., Furie K.L., Kelly P.J. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 2005, 36(7):1581-1587.
8. Freiberger T., et al. Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema. Hum. Immunol. 2002, 63(6):492-494.
9. Goracy I., et al. C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects. J. Appl. Genet. 2009, 50(1):63-67.
10. Helgadottir A., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 2004, 36(3):233-239.
11. Higgins J., et al. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J. Health Serv. Res. Policy 2002, 7(1):51-61.
12. Ibrahim S., El Dessokiy O. Prevalence of methylenetetrahydrofolate gene (MTHFR) C677T polymorphism among chronic hemodialysis patients and its association with cardiovascular disease: a cross-sectional analysis. Clin. Exp. Nephrol. 2009, 13(5):501-507.
13. Isordia-Salas I., et al. The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with idiopathic ischemic stroke in the young Mexican-Mestizo population. Cerebrovasc. Dis. 2010, 29(5):454-459.
14. Kang S.S., et al. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am. J. Hum. Genet. 1991, 48(3):546-551.
15. Kawamoto R., et al. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and ischemic stroke. J. Stroke Cerebrovasc. Dis. 2005, 14(2):67-74.
16. Klerk M., et al. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002, 288(16):2023-2031.
17. Lopaciuk S., et al. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin. Appl. Thromb. Hemost. 2001, 7(4):346-350.
18. Lopez A.D., et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367(9524):1747-1757.
19. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22(4):719-748.
20. Marie S.K., et al. Methylenetetrahydrofolate reductase gene polymorphism is not related to the risk of ischemic cerebrovascular disease in a Brazilian population. Clinics (Sao Paulo) 2007, 62(3):295-300.
21. McIlroy S.P., et al. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002, 33(10):2351-2356.
22. Mejia Mohamed E.H., et al. TT genotype of the methylenetetrahydrofolate reductase C677T polymorphism is an important determinant for homocysteine levels in multi-ethnic Malaysian ischaemic stroke patients. Ann. Acad. Med. Singapore 2011, 40(4):186-191.
23. Miller S.P., et al. Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke 2006, 37(11):2678-2683.
24. Moe K.T., et al. Association of acute ischemic stroke with the MTHFR C677T polymorphism but not with NOS3 gene polymorphisms in a Singapore population. Eur. J. Neurol. 2008, 15(12):1309-1314.
25. Morita H., et al. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler. Thromb. Vasc. Biol. 1998, 18(9):1465-1469.
26. Morizane M., et al. No association of endometriosis with glutathione S-transferase M1 and T1 null mutations in a Japanese population. J. Soc. Gynecol. Investig. 2004, 11(2):118-121.
27. Munafo M.R., Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004, 20(9):439-444.
28. Peddareddygari L.R., et al. An analysis of methylenetetrahydrofolate reductase and glutathione S-transferase omega-1 genes as modifiers of the cerebral response to ischemia. BMC Neurol. 2009, 9:37.
29. Pezzini A., et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke 2007, 38(12):3145-3151.
30. Robins J., Greenland S., Breslow N.E. A general estimator for the variance of the Mantel-Haenszel odds ratio. Am. J. Epidemiol. 1986, 124(5):719-723.
31. Sabino A., et al. Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease. J. Thromb. Thrombolysis 2009, 27(1):82-87.
32. Sazci A., et al. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: dual effect of MTHFR polymorphisms C677T and A1298C. Brain Res. Bull. 2006, 71(1-3):45-50.
33. Shen C.D., et al. Interaction of genetic risk factors confers higher risk for thrombotic stroke in male Chinese: a multicenter case-control study. Ann. Hum. Genet. 2007, 71(Pt 5):620-629.
34. Shi C., et al. The coagulation factor V Leiden, MTHFRC677T variant and eNOS 4ab polymorphism in young Chinese population with ischemic stroke. Clin. Chim. Acta 2008, 396(1-2):7-9.
35. Somarajan B.I., et al. Evaluation of MTHFR C677T polymorphism in ischemic and hemorrhagic stroke patients. A case-control study in a Northern Indian population. J. Neurol. Sci. 2011, 304(1-2):67-70.
36. Szolnoki Z., et al. Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 2003, 74(12):1615-1620.
37. They-They T.P., et al. Methylenehydrofolate reductase (C677T) polymorphism and large artery ischemic stroke subtypes. Acta Neurol. Scand. 2011, 123(2):105-110.
38. Ucar F., et al. MTHFR C677T polymorphism and its relation to ischemic stroke in the Black Sea Turkish population. Am. J. Hematol. 2004, 76(1):40-43.
39. Whitehead A. A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials. Stat. Med. 1997, 16(24):2901-2913.
40. Wu Y., Tomon M., Sumino K. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke: sex difference in Japanese. Kobe J. Med. Sci. 2001, 47(6):255-262.
41. Yingdong Z., Zhigang Z., Yang L. Association of plasma homocysteine level and N5,N10-methylenetetrahydrofolate reductase gene polymorphism with cerebral infarction. Chin. Med. Sci. J. 2002, 17(4):231-235.
42. Zheng Y.Z., et al. Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population. Br. J. Haematol. 2000, 109(4):870-874.
43. Zintzaras E., et al. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J. Hum. Genet. 2005, 50(6):267-275.